Sempra Faces Legal Re-Evaluation Risk as Fraud Probe Resurfaces After 39% Rally

The immediate catalyst is clear. On February 25, 2025, Sempra Energy's stock fell 18.93% in a single day. The trigger was a stark earnings miss: the company reported $3.76 billion in annual revenue, a staggering $970 million below consensus estimates, and slashed its 2025 EPS guidance. This wasn't just a minor disappointment; it was a fundamental reset of near-term expectations that the market punished violently.

That market reaction has since been overshadowed by a powerful rally. Over the past year, the stock has climbed 39.03% to trade near $95. This rebound suggests the market has largely discounted the immediate damage from that February report. Yet, a new legal catalyst has emerged to re-open the wound. Just last month, Pomerantz LLP announced a securities fraud investigation into Sempra's disclosures around that same earnings report. The firm is probing whether the company misled investors about its financial health, a move that could reignite scrutiny and volatility.

The central tension is now set. The market has moved on, but the legal probe acts as a high-conviction catalyst that could force a re-evaluation. For an event-driven strategist, this creates a tactical opportunity: the stock's recent strength may have priced in a clean break from the fraud allegations, but the investigation introduces a new, unresolved risk that could disrupt the rally.

The Mechanics: Weakness or Misrepresentation?

The company's stated reason for the 2025 earnings miss is clear: "higher interest and operating expenses and lower consumption primarily due to mild weather". This explanation frames the problem as a combination of external headwinds and cost pressures. But the hard numbers tell a more complex story.

Sempra's full-year 2025 GAAP earnings of $1.80 billion represent a steep drop from the $2.82 billion recorded in 2024. That's a nearly 36% decline in reported profit. On an adjusted basis, the picture is somewhat better, with earnings of $3.07 billion for 2025 versus $2.97 billion in 2024, showing underlying operational resilience. However, the GAAP miss is the headline number that triggered the market's violent reaction and the subsequent fraud probe.

The recovery plan is ambitious. The company has raised its five-year capital plan to $65 billion, targeting growth in its core Texas and California markets. Management projects EPS growth of 9% or higher through 2029. This roadmap suggests the 2025 miss is being treated as a temporary setback, not a structural failure.

So, was this a one-time weather event or deeper operational rot? The evidence points to a mix. The mild weather explanation for lower consumption is plausible and often cited in utility earnings. Yet, the magnitude of the profit drop, especially when adjusted for significant items like regulatory disallowances and foreign currency impacts, raises questions. The fraud probe hinges on whether the company adequately disclosed these pressures or downplayed them. For now, the mechanics show a company facing a tough year but deploying massive capital to force a turnaround. The tactical question is whether the market's recent rally has already priced in this recovery plan, leaving the stock vulnerable if the fraud investigation uncovers material misrepresentation.

Valuation and the Legal Overhang

The stock's current price reflects a market pricing in significant risk. Trading near its 52-week low with a P/E ratio of 15.5x, the valuation suggests investors are discounting the company's near-term challenges. This discount is the tactical opportunity: the market has punished the February earnings miss and the subsequent fraud probe, leaving the shares at a level that implies a high probability of failure or severe penalties.

Yet, the legal overhang remains a direct financial threat. A successful securities class action could result in substantial damages. While the exact amount is uncertain, such lawsuits often target the full value of the stock drop and investor losses. The probe from Pomerantz LLP, which followed the 18.97% single-day plunge on February 25, 2025, is the clearest catalyst for this risk. A finding of material misrepresentation would not only create a direct liability but also inflict lasting reputational damage, complicating the company's ambitious $65 billion capital plan and growth projections.

Analysts see a path to recovery, but it's not priced in yet. They project 2026 EPS of $3.00 and maintain a fair value estimate of $101.50. That implies a modest upside from current levels, but it assumes the legal cloud clears and the company hits its growth targets. The setup is a classic event-driven tension: the discounted valuation offers a margin of safety against the fraud allegations, but the potential payout from a class action could easily erase that upside if the probe gains traction. For now, the stock trades on the edge of a knife.

Catalysts and Risks: What to Watch

For an event-driven investor, the tactical setup is clear. The stock's 39% rally has priced in a recovery narrative, but the unresolved fraud probe is the overhang that could derail it. The near-term path will be dictated by three specific catalysts and a persistent risk.

First, monitor the legal front. Two firms, Schall and Pomerantz, are investigating the February 2025 report. Watch for any new allegations or, more importantly, any settlement announcements. A settlement could remove the legal uncertainty, potentially freeing the stock from its overhang. Conversely, if the investigation deepens or leads to a formal lawsuit, it would reignite the risk of material damages and distract management from its capital plan.

Second, execution on the ambitious growth roadmap is the counter-catalyst. Sempra has raised its five-year capital plan to $65 billion and projects EPS growth of 9% or higher through 2029. The critical near-term test is 2026. Analysts expect 2026 EPS of $3.00. Meeting or exceeding that guidance would demonstrate the company is navigating its cost pressures and weather headwinds, validating its recovery plan and reducing the perceived risk of misrepresentation.

The key risk is that the legal overhang persists, creating a cloud that deters capital and complicates operations. Even if the stock trades higher on operational news, the unresolved fraud investigation could lead to regulatory friction or make it harder to attract investment for its massive projects. This would undermine the very growth story the stock is now priced to deliver.

The tactical checklist is straightforward: watch for legal developments, track 2026 earnings against the $3.00 EPS target, and assess whether the fraud probe remains a background noise or a looming threat. The stock's recent strength suggests the market is leaning toward the former, but the event-driven opportunity lies in the gap between that optimism and the tangible resolution of the legal risk.